Nonsteroidal Anti-Inflammatory Drugs and Their Neuroprotective Role After an Acute Spinal Cord Injury: A Systematic Review of Animal Models
Authors:
Open Access
- 31 January 2020
- journal article
- review article
- Published by SAGE Publications in Global Spine Journal
- Vol. 11 (3) , 365-377
Abstract
Study Design: Systematic review. Objective: Spinal cord injuries (SCIs) resulting in motor deficits can be devastating injuries resulting in millions of health care dollars spent per incident. Nonsteroidal anti-inflammatory drugs (NSAIDs) are a potential class of drugs that could improve motor function after an SCI. This systematic review utilizes PRISMA guidelines to evaluate the effectiveness of NSAIDs for SCI. Methods: PubMed/MEDLINE, CINAHL, PsycINFO, Embase, and Scopus were reviewed linking the keywords of “ibuprofen,” “meloxicam,” “naproxen,” “ketorolac,” “indomethacin,” “celecoxib,” “ATB-346,” “NSAID,” and “nonsteroidal anti-inflammatory drug” with “spinal.” Results were reviewed for relevance and included if they met inclusion criteria. The SYRCLE checklist was used to assess sources of bias. Results: A total of 2960 studies were identified in the PubMed/MEDLINE database using the above-mentioned search criteria. A total of 461 abstracts were reviewed in Scopus, 340 in CINAHL, 179 in PsycINFO, and 7632 in Embase. A total of 15 articles met the inclusion criteria. Conclusions: NSAIDs’ effectiveness after SCI is largely determined by its ability to inhibit Rho-A. NSAIDs are a promising therapeutic option in acute SCI patients because they appear to decrease cord edema and inflammation, increase axonal sprouting, and improve motor function with minimal side effects. Studies are limited by heterogeneity, small sample size, and the use of animal models, which might not replicate the therapeutic effects in humans. There are no published human studies evaluating the safety and efficacy of these drugs after a traumatic cord injury. There is a need for well-designed prospective studies evaluating ibuprofen or indomethacin after adult spinal cord injuries.Keywords
This publication has 52 references indexed in Scilit:
- A re-assessment of the effects of treatment with a non-steroidal anti-inflammatory (ibuprofen) on promoting axon regeneration via RhoA inhibition after spinal cord injuryExperimental Neurology, 2013
- Factors Influencing the Use and Interpretation of Animal Models in the Development of Parenteral Drug Delivery SystemsThe AAPS Journal, 2011
- RhoA-inhibiting NSAIDs promote axonal myelination after spinal cord injuryExperimental Neurology, 2011
- A Grading System To Evaluate Objectively the Strength of Pre-Clinical Data of Acute Neuroprotective Therapies for Clinical Translation in Spinal Cord InjuryJournal of Neurotrauma, 2011
- Ibuprofen Enhances Recovery from Spinal Cord Injury by Limiting Tissue Loss and Stimulating Axonal GrowthJournal of Neurotrauma, 2009
- How Readily Does Ketorolac Penetrate Cerebrospinal Fluid in Children?The Journal of Clinical Pharmacology, 2008
- Cerebrospinal Fluid Distribution of Ibuprofen After Intravenous Administration in ChildrenPediatrics, 2007
- The Effects of Nonsteroidal Anti-inflammatory Drugs on Posterior Spinal Fusions in the RatSpine, 1996
- Ketorolac penetration into the cerebrospinal fluid of humansJournal of Clinical Anesthesia, 1993
- A Randomized, Controlled Trial of Methylprednisolone or Naloxone in the Treatment of Acute Spinal-Cord InjuryNew England Journal of Medicine, 1990